Free Trial

Xylem (NYSE:XYL) Rating Increased to Buy at Wall Street Zen

Xylem logo with Business Services background

Key Points

  • Xylem has been upgraded from a "hold" to a "buy" rating by Wall Street Zen, indicating increased confidence in the company's stock.
  • Citigroup and Stifel Nicolaus have also raised their target prices for Xylem shares, with new prices set at $152.00 and $175.00 respectively.
  • Xylem reported a quarterly EPS of $1.26, exceeding analysts' expectations of $1.15, along with a 6.1% year-over-year revenue increase to $2.30 billion.
  • Looking to Export and Analyze Xylem Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Xylem (NYSE:XYL - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued on Saturday.

A number of other research firms have also issued reports on XYL. Citigroup reissued a "buy" rating and issued a $152.00 target price (up previously from $137.00) on shares of Xylem in a report on Monday, July 14th. Stifel Nicolaus lifted their price target on Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Royal Bank Of Canada lifted their price target on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research note on Wednesday, April 30th. Raymond James Financial upgraded Xylem to a "hold" rating in a research note on Thursday, May 15th. Finally, Robert W. Baird decreased their price target on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 30th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $151.57.

View Our Latest Report on Xylem

Xylem Trading Down 0.5%

XYL opened at $142.71 on Friday. The firm has a market cap of $34.74 billion, a price-to-earnings ratio of 37.07, a price-to-earnings-growth ratio of 2.49 and a beta of 1.11. Xylem has a 52 week low of $100.47 and a 52 week high of $145.33. The business's 50 day moving average is $131.23 and its two-hundred day moving average is $125.12. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%. The firm's revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.09 earnings per share. On average, research analysts predict that Xylem will post 4.65 EPS for the current year.

Institutional Investors Weigh In On Xylem

Several institutional investors and hedge funds have recently modified their holdings of the stock. Hanson & Doremus Investment Management boosted its position in shares of Xylem by 0.9% in the second quarter. Hanson & Doremus Investment Management now owns 8,516 shares of the industrial products company's stock worth $1,102,000 after buying an additional 77 shares during the period. Princeton Global Asset Management LLC boosted its holdings in Xylem by 2.1% in the second quarter. Princeton Global Asset Management LLC now owns 3,801 shares of the industrial products company's stock valued at $492,000 after purchasing an additional 79 shares during the last quarter. Townsquare Capital LLC boosted its holdings in Xylem by 0.8% in the fourth quarter. Townsquare Capital LLC now owns 11,074 shares of the industrial products company's stock valued at $1,285,000 after purchasing an additional 88 shares during the last quarter. Center for Financial Planning Inc. boosted its holdings in Xylem by 52.0% in the first quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 91 shares during the last quarter. Finally, Keel Point LLC boosted its holdings in Xylem by 4.1% in the fourth quarter. Keel Point LLC now owns 2,371 shares of the industrial products company's stock valued at $275,000 after purchasing an additional 93 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Analyst Recommendations for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines